Capital Market Supervisory Board No. TorChor. 34/2551 Re: Application for and Approval of Offer for Sale of Newly Issued Share Warrants and Newly Issued Underlying Shares ------------------------------ By
11,638.0 (198.0) (1.7%) Normalized Net Profit/3 2,864.7 2,917.9 53.2 1.9% /1 Including other income and share of profit from investments in associates and JVs /2 Gross profit including share of profit from
Net Profit/3 604.5 340.6 (263.8) (43.6%) /1 Including other income and share of profit from investments in associates and JVs /2 Gross profit including share of profit from investments in associates and
- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
after capital increase : 5,000,000 HKD No. of shares purchased : 3,300 Ordinary shares Price per share : HKD 100 per 1 Ordinary shares Total value of the transaction : HKD 330,000 or Baht 1,421,805
. Analysis of Cost and Expenses 1. In Q2 2017, Cost of sales was 3,632 MTHB, increased by 127 MTHB comparing to 2016 or 3.6% due to the increase of sales volumes and higher Glycerin costs from tight market
per share Guarantee amount provided by the company : Previous HKD 1,500,000.- New HKD 500,000.- (7) General description of connected transaction Type of transaction : Transaction regarding grant of
percent of the total issued and paid-up shares of BTSC. 3. Detail of transaction: Type of Interest: 51 percent indirect investment in share capital of LBTG Type of Business of LBTG: Trading and retail
price of all products, especially on PVC, Caustic Soda and ECH according to the market price trends caused by limited export from China. The sales volumes also increased across all products, mainly linked
method Transaction Size = Amount of the consideration Total assets of the Company = 925.11 MB 3,316.83 MB = 27.89 % Note: Closing market price, as of 7 December 2017 at 4.96 Baht per share. 4) Value of